Biobide, part of Bionaturis Group, is attending this week the European edition of the most relevant event on the Cosmetic sector worldwide: In-Cosmetics, hold in Paris on April, 12-14th. In addition, Biobide will have its own booth for the first time: B62.

R&D Management Director of Biobide, Arantza Muriana; and the Study Director, Virginia Caballero, are the delegates of Bionaturis Group in this forum that gathers more than 800 companies from 40 different countries during three hard-working days. Biobide has already arranged several high-level meetings with other exhibitors and visitors. In the latest edition, more than 8,000 people from 100 different nationalities visited this international event.

biobide incosmeticsBesides its use in pharmaceutical, chemical and nutraceutical sectors, the versatility of the zebrafish lets Biobide to diversify to other sectors, such as cosmetic one. In particular, the company offers services of toxicity and efficacy assays, such as whitening/depigmenting efficacy, regeneration, angiogenesis inhibition and others, for the evaluation of cosmetic ingredients or final products. 

About Bionaturis Group

BBD BioPhenix-Biobide was incorporated into Bionaturis Group – which offers cutting-edge biotechnological drugs and services for human and animal health- in 2014. Considered an international benchmark in vaccines research, the biotechnological Group which envisions a global access to health is listed on the stock exchange (ticker BNT).